Guaifenesin And Pseudoephedrine Hcl Tablet, Extended Release
Product Images NDC 46122-801

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin And Pseudoephedrine Hcl (NDC 46122-801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amerisource Bergen, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (600 mg/60 mg (18 Tablet Carton Label))

Package Label-principal Display Panel (600 mg/60 mg (18 Tablet Carton Label))
The text provides information about a medication that is comparable to Mucinex D, containing Guaifenesin and Pseudoephedrine. It includes details on dosage, active ingredients, directions for use, warnings, and contact information. The product is distributed by AmerisourceBergen and mentions it is not distributed by Reckitt Benckiser LLC, the maker of Mucinex® D. This medication is intended to relieve nasal and chest congestion, and it also includes warnings and dosage instructions for different age groups.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.